We're there for consumers when it counts — with the right information, right on time. 70,000+ consumer news stories published ConsumerAffairs is a for-profit company. Your contribution is not tax deductible. Missouri Attorney General Catherine Hanaway has ordered Eli Lilly to stop…
DUBLIN — Governments want to create an EU-wide pharmaceutical “task force” — with the help of the European Commission — to help navigate pressure from Washington, France’s trade minister told POLITICO. The Irish government, which is coordinating EU capitals at the Council of…
Frank Vandenbroucke foresees an extreme increase in European drug prices — or even the withdrawal of drugs from the market. BRUSSELS — The European Union should ready its Anti-Coercion Instrument, otherwise known as its “trade bazooka,” for use against Washington over its…
More states are taking legal action against major insulin manufacturers and pharmacy benefit managers (PBMs), raising questions about whether the rebate arrangements behind prescription drug pricing are contributing to higher costs for patients. Some of the companies being sued include…
Experts at AMCP Nexus say biosimilar launches should prompt payers to revisit step therapy and measure value beyond market share. About 90% of dispensed biologics in British Columbia, the first Canadian province to adopt mandatory switching, are biosimilars, O’Rourke said.2 Manitoba…
WASHINGTON (October 27, 2026) — The Council for Innovation Promotion (C4IP) today raised concerns about potential unintended consequences for American biotechnology innovation under the U.S. Treasury Department’s proposed efforts to protect national security through restrictions on certain outbound investments. C4IP is concerned that the proposal’s…
ST. LOUIS, Mo. (First Alert 4) - Missouri Attorney General Catherine Hanaway announced Monday she has sent a cease-and-desist letter to the drug manufacturer Eli Lilly. The attorney general’s office says Eli Lilly has been imposing unlawful conditions on hospitals participating in…
Five Massachusetts hospitals sued drugmaker Eli Lilly on Tuesday for allegedly violating a federal law that requires pharmaceutical companies to sell outpatient drugs at discounted prices to health care organizations that care for uninsured and poor patients. The suit alleges…
Missouri Attorney General Catherine Hanaway has issued a cease-and-desist letter to Eli Lilly and Company, ordering the pharmaceutical manufacturer to discontinue requirements that her office alleges unlawfully restrict Missouri hospitals’ access to discounted prescription medications through the federal 340B Drug Pricing…
AMCP leaders say PBM reform, new drug pricing models and AI will shape this week’s Nexus meeting in San Diego. Leaders from the Academy of Managed Care Pharmacy (AMCP) spoke with Managed Healthcare Executive about what attendees can expect and…
Policy that moves biotech's business: drug-price negotiation, most-favoured-nation pricing, pharmaceutical tariffs, the BIOSECURE Act and drug-industry lobbying.
An article joins this feed when it matches these terms. Each one is also a search of its own.